RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: papillary adenocarcinoma
Accession: DOID:3112
browse the term
Definition: An adenocarcinoma that derives_from epithelial cells originating in glandular tissue, which form complex papillary structures and exhibit compressive, destructive growth that replaces the normal tissue. (DO)
Synonyms: exact_synonym: infiltrating and papillary adenocarcinoma; infiltrating papillary adenocarcinoma; papillary adenocarcinomas
primary_id: MESH:D000231
xref: ICDO:8260/3; NCI:C2853 ; NCI:C7438
For additional species annotation, visit the
Alliance of Genome Resources .
G
Gli1
GLI family zinc finger 1
ISO
protein:increased expression:stomach
RGD
PMID:17259107
RGD:150340552
NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540
G
Smo
smoothened, frizzled class receptor
ISO
protein:increased expression:stomach
RGD
PMID:17259107
RGD:150340552
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:59,311,041...59,341,281
G
Atm
ATM serine/threonine kinase
susceptibility
ISO
associated with Radiation-Induced Neoplasms;DNA:SNPs,haplotypes:exon 39,intron 22,intron 48: p.D1853N, IVS22-77 T>C, IVS48 + 238 C>G (rs1801516, rs664677, rs609429)
RGD
PMID:19286843
RGD:401850780
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
G
Begain
brain-enriched guanylate kinase-associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,708,010...133,744,264
Ensembl chr 6:133,708,007...133,744,526
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
onset
ISO ISS IMP
DNA:mutation:cds:p.V600E(human) ClinVar Annotator: match by term: Papillary thyroid carcinoma OMIM:188550 DNA:missense mutation:cds;p.V600E(rat) CTD Direct Evidence: marker/mechanism
ClinVar MouseDO CTD RGD
PMID:12068308 PMID:12198537 PMID:12447372 PMID:12619120 PMID:12644542 PMID:12670889 PMID:12794760 PMID:12960123 PMID:14513361 PMID:14602780 PMID:15001635 PMID:15126572 PMID:15181070 PMID:15342696 PMID:15356022 PMID:15386408 PMID:15687339 PMID:15998781 PMID:16015629 PMID:16174717 PMID:16187918 PMID:16772349 PMID:17374713 PMID:17488796 PMID:17785355 PMID:18398503 PMID:19571295 PMID:20818844 PMID:20823850 PMID:21107320 PMID:21107323 PMID:22039425 PMID:22113612 PMID:22281684 PMID:23302800 PMID:23685455 PMID:24512911 PMID:24670642 PMID:24717435 PMID:25079330 PMID:25741868 PMID:25950823 PMID:27222248 PMID:28030816 PMID:28492532 PMID:28854169 PMID:29925953 PMID:31891627 PMID:34476331 PMID:22702340 PMID:31953036 More...
RGD:7241798 , RGD:32716372
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931
G
Brd4
bromodomain containing 4
ISO
mRNA, protein:increased expression:thyroid
RGD
PMID:26707881
RGD:11085509
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,866,997...11,946,923
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
ISO
mRNA:increased expression:thyroid gland
RGD
PMID:23569218
RGD:18337285
NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:155,957,878...155,961,058
G
Cat
catalase
ISO
protein:increased activity:plasma:
RGD
PMID:20204550
RGD:9068926
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Cbx7
chromobox 7
ISO
mRNA,protein,DNA:decreased expression, loss of heterozygosity:thyroid gland: mRNA:decreased expression:thyroid gland (mouse)
RGD
PMID:18701502 PMID:18701502
RGD:9587357 , RGD:9587357
NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346
G
Ccdc6
coiled-coil domain containing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227
G
Ccnd1
cyclin D1
ISO
mRNA:increased expression:thyroid
RGD
PMID:28677753
RGD:13792605
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
G
Cdh1
cadherin 1
ISO
DNA:hypermethylation:promoter
RGD
PMID:25520863
RGD:13792554
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
G
Ctnnb1
catenin beta 1
disease_progression
ISO
mRNA:increased expression:thyroid
RGD
PMID:29498921 PMID:28677753
RGD:13792558 , RGD:13792605
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
G
Dio3
iodothyronine deiodinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985
G
Dio3os
DIO3 opposite strand upstream RNA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
G
Dync1h1
dynein cytoplasmic 1 heavy chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116
G
Kmt2d
lysine methyltransferase 2D
ISO
associated with familial adenomatous polyposis;DNA:missense mutations, nonsense mutation
RGD
PMID:32024448
RGD:150523759
NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:131,859,696...131,900,072
G
Lef1
lymphoid enhancer binding factor 1
ISO
mRNA:increased expression:thyroid
RGD
PMID:28677753
RGD:13792605
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929
G
Lig4
DNA ligase 4
ISO
ClinVar Annotator: match by term: Papillary thyroid carcinoma
ClinVar
PMID:25741868
NCBI chr16:86,220,345...86,228,930
Ensembl chr16:86,220,279...86,229,926
G
Mir127
microRNA 127
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,328,454...134,328,550
Ensembl chr 6:134,328,454...134,328,550
G
Mir134
microRNA 134
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,570,313...134,570,385
G
Mir136
microRNA 136
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,331,335...134,331,416
Ensembl chr 6:134,331,335...134,331,416
G
Mir154
microRNA 154
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,574,352...134,574,435
Ensembl chr 6:134,574,352...134,574,435
G
Mir299a
microRNA 299B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,545,040...134,545,157
G
Mir300
microRNA 300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,559,918...134,559,996
Ensembl chr 6:134,559,910...134,559,999
G
Mir323
microRNA 323
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,546,944...134,547,029
Ensembl chr 6:134,546,944...134,547,029
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,321,142...134,321,238
Ensembl chr 6:134,321,141...134,321,237
G
Mir3581
microRNA 3581
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,579,184...134,579,263
G
Mir370
microRNA 370
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,354,491...134,354,569
Ensembl chr 6:134,354,491...134,354,569
G
Mir377
microRNA 377
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,576,456...134,576,527
G
Mir381
microRNA 381
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,562,381...134,562,441
G
Mir382
microRNA 382
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,569,944...134,570,023
G
Mir409
microRNA 409
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,579,185...134,579,261
G
Mir410
microRNA 410
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,579,763...134,579,838
Ensembl chr 6:134,579,759...134,579,839
G
Mir411
microRNA 411
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,544,594...134,544,669
Ensembl chr 6:134,544,589...134,544,684
G
Mir412
microRNA 412
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,579,337...134,579,406
Ensembl chr 6:134,579,331...134,579,410
G
Mir431
microRNA 431
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,326,449...134,326,562
Ensembl chr 6:134,326,449...134,326,562
G
Mir433
microRNA 433
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,327,358...134,327,450
Ensembl chr 6:134,327,351...134,327,456
G
Mir487b
microRNA 487b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,562,890...134,562,971
Ensembl chr 6:134,562,890...134,562,971
G
Mir494
microRNA 494
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:134,550,114...134,550,198
G
Mir496
microRNA 496
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,575,049...134,575,127
Ensembl chr 6:134,575,049...134,575,127
G
Mir770
microRNA 770
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:134,298,084...134,298,159
Ensembl chr 6:134,298,076...134,298,169
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
mRNA:increased expression:thyroid
RGD
PMID:28677753
RGD:13792605
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
G
Nkx2-1
NK2 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr 6:79,731,677...79,735,952
Ensembl chr 6:79,731,677...79,736,441
G
Palb2
partner and localizer of BRCA2
ISO
ClinVar Annotator: match by term: Papillary thyroid carcinoma
ClinVar
PMID:25085752 PMID:25741868 PMID:28492532
NCBI chr 1:186,096,312...186,120,284
Ensembl chr 1:186,096,312...186,120,302
G
Plau
plasminogen activator, urokinase
severity
ISO
mRNA:increased expression:thyroid gland (human)
RGD
PMID:22702340
RGD:7241798
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
G
Ppp2r5c
protein phosphatase 2, regulatory subunit B', gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:135,282,947...135,419,591
Ensembl chr 6:135,324,067...135,419,597
G
Rap1gap
Rap1 GTPase-activating protein
ISO
protein:decreased expression:thyroid gland (human)
RGD
PMID:19066305
RGD:9835342
NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:155,157,558...155,222,622
G
Ret
ret proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:152,998,812...153,040,556
G
Runx3
RUNX family transcription factor 3
ISO
DNA:hypermethylation:promoter
RGD
PMID:25520863
RGD:13792554
NCBI chr 5:152,644,270...152,702,835
Ensembl chr 5:152,644,270...152,702,835
G
Rxrg
retinoid X receptor gamma
ISO
mRNA:increased expression:thyroid
RGD
PMID:28677753
RGD:13792605
NCBI chr13:82,276,330...82,318,097
Ensembl chr13:82,276,291...82,318,095
G
Snai1
snail family transcriptional repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 3:176,667,476...176,671,965
G
Snai2
snail family transcriptional repressor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
G
Tp53
tumor protein p53
susceptibility
ISO
associated with Radiation-Induced Neoplasms;DNA:SNPs, haplotypes:exon 4: p.R72P (rs1042522) (human)
RGD
PMID:19286843
RGD:401850780
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Tpm3
tropomyosin 3
ISO
mRNA:increased expression:thyroid
RGD
PMID:28677753
RGD:13792605
NCBI chr 2:177,812,534...177,842,661
Ensembl chr 2:177,814,883...177,842,660
G
Wars1
tryptophanyl-tRNA synthetase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645
G
Wdr20
WD repeat domain 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 6:135,572,502...135,642,688
Ensembl chr 6:135,572,893...135,642,688
G
Wdr3
WD repeat domain 3
susceptibility
ISO
DNA:snps, haplotype:introns: c.500+239G>A, c.*1-2382A>C (rs3765501, rs4658973) (human)
RGD
PMID:20578902
RGD:11041898
NCBI chr 2:190,194,474...190,217,087
Ensembl chr 2:190,194,474...190,217,087
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:SNP:exon 10: p.R399Q (rs25487) (Human)
RGD
PMID:19286843
RGD:401850780
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613
G
Zeb1
zinc finger E-box binding homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745
G
Zeb2
zinc finger E-box binding homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
G
Foxe1
forkhead box E1
ISO
ClinVar Annotator: match by term: FOXE1-related disorder | ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 4
OMIM ClinVar
PMID:25381600 PMID:25741868 PMID:28444304 PMID:32428920
NCBI chr 5:65,425,630...65,428,438
Ensembl chr 5:65,425,630...65,428,438
G
Habp2
hyaluronan binding protein 2
susceptibility
ISO
ClinVar Annotator: match by term: HABP2-related condition | ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 5
ClinVar OMIM
PMID:12138371 PMID:12578864 PMID:15486068 PMID:25741868 PMID:26222560 PMID:26581001 PMID:26581002 PMID:26581003 PMID:26581004 PMID:26581005 More...
NCBI chr 1:265,321,084...265,355,375
Ensembl chr 1:265,303,172...265,355,374
G
Kras
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 1
ClinVar
NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
G
Nkx2-1
NK2 homeobox 1
ISO
OMIM
NCBI chr 6:79,731,677...79,735,952
Ensembl chr 6:79,731,677...79,736,441
G
Pcm1
pericentriolar material 1
ISO
ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 1
ClinVar
PMID:10980597 PMID:25741868
NCBI chr16:57,711,833...57,808,842
Ensembl chr16:57,711,833...57,808,599
G
Rint1
RAD50 interactor 1
ISO
ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 1
ClinVar
PMID:16199547 PMID:25741868 PMID:28492532 PMID:31204009 PMID:33471991
NCBI chr 4:12,211,806...12,248,117
Ensembl chr 4:12,213,156...12,248,117
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all